KAMADA LTD (KMDA) Stock Price, Forecast & Analysis
USA - NASDAQ:KMDA - IL0010941198 - Common Stock
KMDA Key Statistics, Chart & Performance
The current stock price of KMDA is 6.66 USD. In the past month the price decreased by -2.06%. In the past year, price increased by 11%.
KMDA Latest News, Press Relases and Analysis
KMDA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 23.19 | 387.16B | ||
| AMGN | AMGEN INC | 14.64 | 172.38B | ||
| GILD | GILEAD SCIENCES INC | 14.51 | 147.46B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.59 | 104.98B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.61 | 69.69B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 868.04 | 58.03B | ||
| INSM | INSMED INC | N/A | 40.10B | ||
| NTRA | NATERA INC | N/A | 27.39B | ||
| BIIB | BIOGEN INC | 9.29 | 22.80B | ||
| INCY | INCYTE CORP | 16.51 | 20.70B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.01 | 20.30B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 36.45 | 15.11B |
Related stock screener links
About KMDA
Company Profile
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Company Info
KAMADA LTD
2 Holtzman St., Science Park
Rehovot 7670402 IL
CEO: Amir London
Employees: 420
Phone: 97289406472
KAMADA LTD / KMDA FAQ
Can you describe the business of KAMADA LTD?
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Can you provide the latest stock price for KAMADA LTD?
The current stock price of KMDA is 6.66 USD. The price increased by 0.6% in the last trading session.
What is the dividend status of KAMADA LTD?
KAMADA LTD (KMDA) has a dividend yield of 3%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of KMDA stock?
KMDA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Is KAMADA LTD (KMDA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on KMDA.
Is KAMADA LTD (KMDA) expected to grow?
The Revenue of KAMADA LTD (KMDA) is expected to grow by 12.07% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
How many employees does KAMADA LTD have?
KAMADA LTD (KMDA) currently has 420 employees.
KMDA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to KMDA. When comparing the yearly performance of all stocks, KMDA turns out to be only a medium performer in the overall market: it outperformed 53.66% of all stocks.
KMDA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to KMDA. KMDA has an excellent profitability rating, but there are some minor concerns on its financial health.
KMDA Financial Highlights
Over the last trailing twelve months KMDA reported a non-GAAP Earnings per Share(EPS) of 0.34. The EPS increased by 25.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.21% | ||
| ROA | 5.16% | ||
| ROE | 7.31% | ||
| Debt/Equity | 0.04 |
KMDA Forecast & Estimates
9 analysts have analysed KMDA and the average price target is 16.32 USD. This implies a price increase of 145.05% is expected in the next year compared to the current price of 6.66.
For the next year, analysts expect an EPS growth of 50.06% and a revenue growth 12.07% for KMDA